Monday June 22, 0800-1030

Leonard Jeffrey Medeirios, The University of Texas MD Anderson Cancer Center

Diffuse Large B-cell Lymphoma


At the end of this session, participants will be able to:

Diagnose morphologic variants and subtypes of diffuse large B-cell lymphoma recognized in the World Health Organization classification.
Recognize clinicopathologic and immunophenotypic findings that have prognostic value in patients with diffuse large B-cell lymphoma.
Apply results of conventional cytogenetic analysis and fluorescence in situ hybridization to enhance diagnosis of diffuse large B-cell lymphoma.

Question Title

* 1. Please type your first and last name below. To obtain CME/CPD, you must fill out an evaluation for each educational event attended. Filling in the field below will ensure you receive credit for completing this evaluation. Evaluations remain confidential and anonymous - The field is randomized and deleted when CME/CPD is claimed.

Question Title

* 2. Please take a few minutes of your time to evaluate the scientific session.

  Yes No
Session objectives as stated above were adequately met.
The session met my expectations.
The session content was relevant and/or applicable to my work.
Adequate time was allocated for questions/discussion/interaction.
I would like to have had this session recorded for future viewing/listening.

Question Title

* 3. Outcomes: As a result of attending this session, I am planning to:

  Yes No
Discuss with Colleagues
Pursue additional learning activities
Complete a personal learning project
Change my practice

Question Title

* 4. If you answered yes, please indicate/describe what additional learning or knowledge you intend to pursue:

Question Title

* 5. If you answered yes, please indicate what changes you intend to integrate into practice: